Strangely behaving fluidic oscillator od Peszynski K., Tesař V.

Dokumenty pełnotekstowe

Damage is independent of disease activity in systemic vasculitis od McRorie, E, Luqmani, R, Dadoniene, J, Rychlik, I, Tesar, V, Nowack, R

Prospective clinical trial of Gusperimus (deoxyspergualin) in refractory Wegener's granulomatosis od Flossmann, O, Baslund, B, Bruchfeld, A, Cohen Tervaert, J, Heinzel, P, Hellmich, B, Luqmani, R, Tesar, V, Jayne, D

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. od Flossmann, O, Baslund, B, Bruchfeld, A, Tervaert, J, Hall, C, Heinzel, P, Hellmich, B, Luqmani, R, Nemoto, K, Tesar, V, Jayne, DR

Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP). od Haynes, R, Staplin, N, Emberson, J, Herrington, W, Tomson, C, Agodoa, L, Tesar, V, Levin, A, Lewis, D, Reith, C, Baigent, C, Landray, M

Evaluating the contribution of the cause of kidney disease to prognosis in ckd: Results from the Study of Heart and Renal Protection (SHARP) od Haynes, R, Staplin, N, Emberson, J, Herrington, W, Tomson, C, Agodoa, L, Tesar, V, Levin, A, Lewis, D, Reith, C, Baigent, C, Landray, M

Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS od Jones, R, Tervaert, J, Hauser, T, Luqmani, R, Peh, C, Savage, C, Segelmark, M, Tesar, V, Van Paassen, P, Walsh, M, Walsh, D, Westman, K, Jayne, D

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection. od Herrington, W, Emberson, J, Staplin, N, Blackwell, L, Fellström, B, Walker, R, Levin, A, Hooi, L, Massy, Z, Tesar, V, Reith, C, Haynes, R, Baigent, C, Landray, M

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. od Jones, R, Tervaert, J, Hauser, T, Luqmani, R, Morgan, MD, Peh, C, Savage, C, Segelmark, M, Tesar, V, van Paassen, P, Walsh, D, Walsh, M, Westman, K, Jayne, DR

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. od de Groot, K, Harper, L, Jayne, DR, Flores Suarez, L, Gregorini, G, Gross, W, Luqmani, R, Pusey, C, Rasmussen, N, Sinico, R, Tesar, V, Vanhille, P, Westman, K, Savage, C

Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial od Harper, L, De Groot, K, Jayne, D, Flores Suarez, L, Gregorini, G, Gross, W, Luqmani, R, Pusey, C, Rasmussen, N, Sinico, R, Tesar, V, Vanhille, P, Westman, K, Savage, C

Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis od Scott, J, White, A, Walsh, C, Aslett, L, Rutherford, MA, Ng, J, Judge, C, Sebastian, K, O’Brien, S, Kelleher, J, Power, J, Conlon, N, Moran, SM, Luqmani, RA, Merkel, PA, Tesar, V, Hruskova, Z, Little, MA

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. od Suppiah, R, Mukhtyar, C, Flossmann, O, Alberici, F, Baslund, B, Batra, R, Brown, D, Holle, J, Hruskova, Z, Jayne, DR, Judge, A, Little, M, Palmisano, A, Stegeman, C, Tesar, V, Vaglio, A, Westman, K, Luqmani, R

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. od Harper, L, Morgan, MD, Walsh, M, Hoglund, P, Westman, K, Flossmann, O, Tesar, V, Vanhille, P, de Groot, K, Luqmani, R, Flores-Suarez, L, Watts, R, Pusey, C, Bruchfeld, A, Rasmussen, N, Blockmans, D, Savage, C, Jayne, D

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index od Suppiah, R, Flossmann, O, Mukhtyar, C, Alberici, F, Baslund, B, Brown, D, Hasan, N, Holle, J, Hruskova, Z, Jayne, D, Judge, A, Little, M, Merkel, P, Palmisano, A, Seo, P, Stegeman, C, Tesar, V, Vaglio, A, Westman, K, Luqmani, R

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA) od Suppiah, R, Flossman, O, Mukhtyar, C, Alberici, F, Baslund, B, Brown, D, Hasan, N, Holle, J, Hruskova, Z, Jayne, D, Judge, A, Little, M, Merkel, P, Palmisano, A, Seo, P, Stegeman, C, Tesar, V, Vaglio, A, Westman, K, Luqmani, R

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index. od Suppiah, R, Flossman, O, Mukhtyar, C, Alberici, F, Baslund, B, Brown, D, Hasan, N, Holle, J, Hruskova, Z, Jayne, D, Judge, A, Little, M, Merkel, P, Palmisano, A, Seo, P, Stegeman, C, Tesar, V, Vaglio, A, Westman, K, Luqmani, R

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts od Yates, M, Watts, R, Bajema, I, Cid, M, Crestani, B, Hauser, T, Hellmich, B, Holle, J, Laudien, M, Little, MA, Luqmani, RA, Mahr, A, Merkel, P, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, KWA, Vaglio, A, Yalçındağ, N, Jayne, DR, Mukhtyar, C

OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis od Yates, M, Watts, R, Bajema, I, Cid, M, Crestani, B, Hauser, T, Hellmich, B, Holle, J, Laudien, M, Little, M, Luqmani, R, Mahr, A, Merkel, P, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, K, Vaglio, A, Yalçındağ, N, Jayne, D, Mukhtyar, C

EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS od Yates, M, Watts, R, Nilufer, N, Bajema, I, Little, M, Segelmark, M, Tesar, V, Westman, K, Vaglio, A, Mooney, J, Cid, M, Crestani, B, Hauser, T, Hellmich, B, Holle, J, Laudien, M, Luqmani, R, Mahr, A, Merkel, P, Mills, J, Jayne, D, Mukhtyar, C